Alkermes plc (ALKS) vs Regencell Bioscience Holdings Limited (RGC)
- Alkermes plc ALKS 41.22 +2.79%
- Regencell Bioscience Holdings Limited RGC 9.59 +0.74%
Alkermes plc and Regencell Bioscience Holdings Limited are both Drug Manufacturers Specialty & Generic companies. Alkermes plc is the larger, with a market value of $6.7B against $4.7B — 1.4× the size. Regencell Bioscience Holdings Limited has negative trailing earnings, so its P/E is not meaningful; Alkermes plc trades at 102×. Alkermes plc has the higher net margin (3.97% vs 0.00%) and the higher return on invested capital (2.76% vs 0.00%). Across the 12 metrics below, Alkermes plc leads on 10 and Regencell Bioscience Holdings Limited on 2.
Valuation
Profitability
| Metric | ALKS | RGC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 84.56% | — | 53.94% |
| Operating margin | 7.03% | — | 0.00% |
| Net margin | 3.97% | 0.00% | 0.00% |
| Free cash flow margin | 13.35% | 0.00% | 0.00% |
| Return on equity | 3.85% | 0.00% | (0.40%) |
| Return on assets | 1.99% | 0.00% | (3.32%) |
| Return on invested capital | 2.76% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack